Results 41 to 50 of about 3,911,704 (314)
Background Pirfenidone is an antifibrotic agent approved for the treatment of idiopathic pulmonary fibrosis (IPF). The drug is available for Polish patients with IPF since 2017. The PolExPIR study aimed to describe the real-world data (RWD) on the Polish
Sebastian Majewski +25 more
doaj +1 more source
Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. [PDF]
Background The rise in non-communicable diseases in developing countries has gained increased attention. Given that around 80% of deaths related to non-communicable diseases occur in low- and middle-income countries, there is a need for local knowledge ...
Smeeth, Liam +5 more
core +1 more source
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges. [PDF]
Patients with progressive fibrosing interstitial lung diseases (fILD) have increased morbidity and mortality. Lung fibrosis can be associated with lung cancer.
Jacques Cadranel +12 more
core +2 more sources
Background: Large pericardial effusion (LPE) is associated with high mortality. In patients with cardiac tamponade or with suspected bacterial etiology of pericardial effusion, urgent pericardial decompression is necessary.
Małgorzata Dybowska +7 more
doaj +1 more source
Interstitial lung disease [PDF]
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Antoniou, Katerina M. +5 more
openaire +4 more sources
ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider +15 more
wiley +1 more source
Progressive fibrosis in interstitial lung diseases — proposed definition and management [PDF]
Interstitial lung diseases may have an unpredictably progressive course, which is manifested as progression of pulmonary fibrosis, causing an increasing impairment of lung function affecting a poor prognosis.
Piotrowski, Wojciech Jerzy; Department of Pneumology and Allergy, Medical University of Lodz, Lodz, Poland +1 more
core +1 more source
Conclusion: A reliable predictor in the current study of men and women with COVID-19 was N/LP ratio.
Jafar Mohammadshahi +6 more
doaj +1 more source
The onset of the COVID-19 pandemic allowed physicians to gain experience in lung ultrasound (LUS) during the acute phase of the disease. However, limited data are available on LUS findings during the recovery phase.
Katarzyna Zimna +6 more
doaj +1 more source
Background Recently, a novel humanized mouse model for systemic sclerosis (SSc) was established by transferring peripheral blood mononuclear cells (PBMC) from patients with SSc to Rag2 −/− Il2rg −/− immunodeficient mice. Here, we aimed to investigate the
Yaqing Shu +13 more
doaj +1 more source

